Skip to content

Assessing the effectiveness of a lateral glide cervical spine mobilisation on cervicobrachial (neck and arm) pain

A randomised controlled trial to assess the effectiveness of a lateral glide cervical spine mobilisation on cervicobrachial (neck and arm) pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN62431186
Enrollment
96
Registered
2011-04-14
Start date
2009-06-24
Completion date
Unknown
Last updated
2017-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal pain Musculoskeletal Diseases Other dorsopathies, not elsewhere classified

Interventions

Patients will be randomised to 1. Lateral glide with self-management 2. Self-management

Sponsors

University of Birmingham (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 - 65 years experiencing CBS (described as pain originating in the neck with associated pain radiating below the level of the shoulder joint into the arm) with or without parasthesia and or weakness in a dermatomal distribution 2. Had symptoms for greater than 6 weeks 3. Adequate knowledge of English to participate in a neuro-musculoskeletal examination and to answer the study questionnaire 4. Able to attend assessment and treatment appointments 5. Will have verbally agreed to attend the review appointment at 6, 26 and 52 weeks following initiation of the treatment

Exclusion criteria

Exclusion criteria: 1. Presenting with any red flags: severe unremitting night pain, unexplained weight loss, history of cancer, general malaise, and constant unvarying pain 2. Bilateral arm symptoms 3. Signs and symptoms strongly suggestive of thoracic outlet syndrome or a specificperipheral pathology e.g. adhesive capsulitis, sub acromial impingement etc. 4. Specific pathology affecting nerve function e.g. multiple sclerosis, known peripheral vascular disease, diabetes 5. Known specific pathology affecting systemic joint function e.g. rheumatoid arthritis, ankylosing spondylitis 6. Cervical spine surgery, botulinum toxin injections or epidural injections to cervical spine or planned imminent treatment 7. Having other forms of manual therapy for their CBS symptoms e.g. osteopathy or chiropractics 8. Involved in compensation and or litigation associated with neck and or upper limb pain 9. Already involved in a research trial

Design outcomes

Primary

MeasureTime frame
Pain, assessed by Visual Analogue Score (VAS)

Secondary

MeasureTime frame
1. Short Form 36-item Health Survey (SF36) (RAND) 2. Neck and Upper Limb Index (NULI) 3. Tampra scale of Kinesiophobia 4. Global Rating of Change (GROC) 5. Self-Administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) 6. Upper limb nerve extensability test 7. Cervical Active Range Of Motion (AROM)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026